SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000886163-16-000165
Filing Date
2016-04-12
Accepted
2016-04-12 16:05:04
Documents
5
Effectiveness Date
2016-04-12

Document Format Files

Seq Description Document Type Size
1 DEFA14A lgndproxynoticedoc.htm DEFA14A 27538
2 a02bfceligandpharmacommo001.jpg GRAPHIC 229336
3 a02bfceligandpharmacommo002.jpg GRAPHIC 102572
4 a02bffbligandpharmanotic001.jpg GRAPHIC 207587
5 a02bffbligandpharmanotic002.jpg GRAPHIC 168504
  Complete submission text file 0000886163-16-000165.txt   991070
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 161567302
SIC: 2834 Pharmaceutical Preparations